Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Molecules for Decision Making
NCT04384562Completed
- Sponsor
- University of Zurich
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylphenidate, reboxetine and nicotine (4 arms), sponsored by University of Zurich. Primary endpoints: Choice data at 1 hour and Response time data at 1 hour. Started Dec 2020; status: completed.
02
Drugs
methylphenidatereboxetinenicotine
Beyond the preview
Go deeper on NCT04384562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04384562.